These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31276860)

  • 41. Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
    Izquierdo G; O'Connor P; Montalban X; von Rosenstiel P; Cremer M; de Vera A; Sfikas N; Francis G; Radue EW; Kappos L
    Mult Scler; 2014 Jun; 20(7):877-81. PubMed ID: 24293455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fingolimod-induced immune thrombocytopenic purpura (ITP).
    Mukharesh L; Rothstein TL
    Clin Neurol Neurosurg; 2020 Oct; 197():106081. PubMed ID: 32739722
    [No Abstract]   [Full Text] [Related]  

  • 43. Fingolimod-associated macular oedema.
    Jasani KM; Sharaf N; Rog D; Aslam T
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28619738
    [No Abstract]   [Full Text] [Related]  

  • 44. Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection.
    Saccà F; Pane C; De Rosa A; Matarazzo M; Brescia Morra V
    Neurol Sci; 2017 Mar; 38(3):501-502. PubMed ID: 27699497
    [No Abstract]   [Full Text] [Related]  

  • 45. Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth.
    Kraemer M; Weber R; Herold M; Berlit P
    Mult Scler; 2015 Oct; 21(11):1473-5. PubMed ID: 26283695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis.
    Thomas K; Proschmann U; Ziemssen T
    Expert Opin Pharmacother; 2017 Oct; 18(15):1649-1660. PubMed ID: 28844164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Herpes zoster laryngitis in a patient treated with fingolimod.
    Hagiya H; Yoshida H; Shimizu M; Motooka D; Nakamura S; Iida T; Yamamoto N; Akeda Y; Tomono K
    J Infect Chemother; 2016 Dec; 22(12):830-832. PubMed ID: 27553068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ventricular arrhythmia in a male MS patient on fingolimod.
    van Pesch V; Marchandise S; El Sankari S; Sindic C
    Acta Neurol Belg; 2015 Mar; 115(1):77-9. PubMed ID: 24710722
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
    Grebenciucova E; Reder AT; Bernard JT
    Mult Scler Relat Disord; 2016 Sep; 9():158-62. PubMed ID: 27645366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Switching therapy from natalizumab to fingolimod: reduction of the washout time?].
    Sánchez-Gundín J; Flor García A; Martí Gil C; Gómez Romero L
    Farm Hosp; 2015 Sep; 39(5):314-5. PubMed ID: 26546944
    [No Abstract]   [Full Text] [Related]  

  • 51. The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis.
    Datt J; Baldock L; Pull E; Webber B
    Mult Scler Relat Disord; 2016 Jan; 5():40-6. PubMed ID: 26856942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fingolimod treatment after natalizumab-related progressive multifocal leukoencephalopathy: three new cases.
    Peaureaux D; Pignolet B; Biotti D; Bucciarelli F; Gaina J; Bucur C; Clanet M; Martin-Blondel G; Brassat D
    Mult Scler; 2015 Apr; 21(5):671-2. PubMed ID: 25305251
    [No Abstract]   [Full Text] [Related]  

  • 53. Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis.
    Fruschelli M; Capozzoli M; Gelmi MC; Masi G; Annunziata P
    Int Ophthalmol; 2019 Apr; 39(4):777-781. PubMed ID: 29500696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.
    Hunter SF; Agius M; Miller DM; Cutter G; Barbato L; McCague K; Meng X; Agashivala N; Chin P; Hollander E
    J Neurol Sci; 2016 Jun; 365():190-8. PubMed ID: 27206905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis.
    Wicks P; Rasouliyan L; Katic B; Nafees B; Flood E; Sasané R
    BMC Res Notes; 2016 Sep; 9(1):434. PubMed ID: 27604188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fulminant multifocal relapse in a fingolimod-treated multiple sclerosis patient.
    Breville G; Lascano AM; Merkler D; Roth S; Lalive PH
    Mult Scler Relat Disord; 2019 Sep; 34():63-65. PubMed ID: 31229736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
    Alping P; Frisell T; Novakova L; Islam-Jakobsson P; Salzer J; Björck A; Axelsson M; Malmeström C; Fink K; Lycke J; Svenningsson A; Piehl F
    Ann Neurol; 2016 Jun; 79(6):950-8. PubMed ID: 27038238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study].
    Mallada-Frechin J; Meca-Lallana V; Barrero F; Martinez-Gines ML; Marzo-Sola ME; Ricart J; Garcia E; En Representacion de Los Investigadores Del Estudio Ms Next ERLIDEMN
    Rev Neurol; 2018 Sep; 67(5):157-167. PubMed ID: 30047118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe.
    Giovannoni G; de Jong B; Derfuss T; Izquierdo G; Mazibrada G; Molyneux P; Nicholas R; Overell J; Ziemssen T; Juliusson G
    Mult Scler Relat Disord; 2015 Jan; 4(1):83-4. PubMed ID: 25787058
    [No Abstract]   [Full Text] [Related]  

  • 60. Teaching NeuroImage: Cryptococcus in a Woman With Multiple Sclerosis on Fingolimod.
    Gibson S; Mcgraw C
    Neurology; 2024 Jan; 102(2):e208027. PubMed ID: 38165340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.